Advertisement

Topics

Quad Technologies Company Profile

06:55 EDT 19th June 2018 | BioPortfolio

Established in 2013, Quad Technologies is a developer of novel cell separation technology with significant advantages over conventional approaches for the binding and releasing of rare cells. With a product driven business model, the company is committed to answering the needs of researchers working in cell separation applications – www.quadtechnologies.com


News Articles [203 Associated News Articles listed on BioPortfolio]

Bio-Techne to acquire Quad Technologies

Bio-Techne Corporation announced it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be f...

Sartorius inks deal for Quad's T cell activation tech

Quad Technologies has teamed with Sartorius Stedim Biotech to expand the reach of its T-cell activation reagent for cell and gene therapy production.

Quad Technologies Partners With Sartorius Stedim Biotech On CD3/CD28 T Cell Activation Product

Quad Technologies, a visionary innovator in cell and gene therapy bioprocessing, today announced a collaboration with Sartorius Stedim Biotech, a leading provider of cuttin...

Quad-strain meningococcal vaccine to be added to Australia’s NIP

To help protect our youngest Australians from the devastating consequences of meningococcal, the Australian…

OWC Offers Cross-Platform Flexibility and RAID Performance with the Mercury Elite Pro Quad

Key Features Four SATA drive bays support up to 48TB of storage in a desktop solution Up to 947MB/s of USB 3.1 Gen 2 performance Read more...

Paralyzed Veterans of America Announces First Annual Quad Rugby Invitational

The event will include a free clinic on February 23at 5:00 p.m.led by Paralyzed Veterans' partner, Oscar Mike, and will be catered Read more...

SCIEX Launches the Citrine? Triple Quad? MS/MS Systems in Europe

The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and ...

IDT Introduces 46Gbps SMT Quad Channel Linear Modulator Driver for 400G Long Haul and Metro ...

The IDT® GX74470 46Gbps linear driver, integrates four linear driver channels in a high-performance surface mount package for direct connection to an OIF-compliant LiNb 2 Read more...

PubMed Articles [345 Associated PubMed Articles listed on BioPortfolio]

Influence of Alveolar Bone Defects on the Stress Distribution in Quad Zygomatic Implant-Supported Maxillary Prosthesis.

The purpose of this study was to create three-dimensional composite models of quad zygomatic implant-supported maxillary prostheses with a variety of alveolar bone defects around implant sites, and to...

Lower-limb reconstruction with chimeric flaps: The quad flap.

Early soft-tissue coverage is critical for treating traumatic open lower-extremity wounds. As free-flap reconstruction evolves, injuries once thought to be nonreconstructable are being salvaged. Free-...

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.

Purpose Selinexor, a first-in-class, oral, selective exportin 1 (XPO1) inhibitor, induces apoptosis in cancer cells through nuclear retention of tumor suppressor proteins and the glucocorticoid recept...

Three-dimensional Technologies in Orthopedics.

New 3-dimensional digital technologies are revolutionizing orthopedic clinical practice, allowing structures of any complexity to be manufactured in just hours. Such technologies can make surgery for ...

'Omic' technologies as a helpful tool in radioecological research.

This article presents a brief review of the modern 'omic' technologies, namely genomics, epigenomics, transcriptomics, proteomics, and metabolomics, as well as the examples of their possible use in ra...

Clinical Trials [401 Associated Clinical Trials listed on BioPortfolio]

Study of the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 (QUAD) Versus Atripla(R) in HIV Infected, Antiretroviral Treatment-Naive Adults

The objective of this study is to evaluate the safety and efficacy of a single tablet regimen containing fixed doses of elvitegravir/emtricitabine/tenofovir disoproxil fumarate/GS 9350 ver...

Efficacy Study of the Octapolar Lead in Patients With Failed Back Surgery Syndrome (FBSS) With Chronic Pain

Spinal cord stimulation (SCS) has been used for over 40 years to treat neuropathic pain. Various clinical studies have shown a beneficial effect of SCS on pain in patients with Failed Back...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Companies [1266 Associated Companies listed on BioPortfolio]

Quad Technologies

Established in 2013, Quad Technologies is a developer of novel cell separation technology with significant advantages over conventional approaches for the binding and releasing of...

Quad-C Management

Founded in 1989 and headquartered in Charlottesville, Virginia, Quad-C is a middle market private equity firm focused on investing in well-established business services, consumer,...

Quad/Graphics, Inc.

Quad/Graphics (NYSE: QUAD) is a global marketing services provider that helps brand owners market their products, services and content more efficiently and effectively. To do this...

Quad/Graphics

At the forefront of innovation for 45 years, Quad/Graphics (NYSE: QUAD) is a leading print and marketing services provider focused on helping brand owners market their products, s...

Quad-C Management, Inc.

More Information about "Quad Technologies" on BioPortfolio

We have published hundreds of Quad Technologies news stories on BioPortfolio along with dozens of Quad Technologies Clinical Trials and PubMed Articles about Quad Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quad Technologies Companies in our database. You can also find out about relevant Quad Technologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record